The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Metabolically Healthy Obesity and Development of Chronic Kidney Disease: A Cohort Study
Abstract
BACKGROUND: The risk for chronic kidney disease (CKD) among obese persons without obesity-related metabolic abnormalities, called metabolically healthy obesity, is largely unexplored. OBJECTIVE: To investigate the risk for incident CKD across categories of body mass index in a large cohort of metabolically healthy men and women. DESIGN: Prospective cohort study. SETTING: Kangbuk Samsung Health Study, Kangbuk Samsung Hospital, Seoul, South Korea. PARTICIPANTS: 62 249 metabolically healthy, young and middle-aged men and women without CKD or proteinuria at baseline. MEASUREMENTS: Metabolic health was defined as a homeostasis model assessment of insulin resistance less than 2.5 and absence of any component of the metabolic syndrome. Underweight, normal weight, overweight, and obesity were defined as a body mass index less than 18.5 kg/m2, 18.5 to 22.9 kg/m2, 23 to 24.9 kg/m2, and 25 kg/m2 or greater, respectively. The outcome was incident CKD, defined as an estimated glomerular filtration rate less than 60 mL/min/1.73 m2. RESULTS: During 369 088 person-years of follow-up, 906 incident CKD cases were identified. The multivariable-adjusted differences in 5-year cumulative incidence of CKD in underweight, overweight, and obese participants compared with normal-weight participants were -4.0 (95% CI, -7.8 to -0.3), 3.5 (CI, 0.9 to 6.1), and 6.7 (CI, 3.0 to 10.4) cases per 1000 persons, respectively. These associations were consistently seen in all clinically relevant subgroups. LIMITATION: Chronic kidney disease was identified by a single measurement at each visit. CONCLUSION: Overweight and obesity are associated with an increased incidence of CKD in metabolically healthy young and middle-aged participants. These findings show that metabolically healthy obesity is not a harmless condition and that the obese phenotype, regardless of metabolic abnormalities, can adversely affect renal function. PRIMARY FUNDING SOURCE: None.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Self-citationAlberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Marginal Structural Models and Causal Inference in Epidemiology
Robins, J. M., Hernán, M. Á., & Brumback, B. (2000) · Epidemiology · doi:10.1097/00001648-200009000-00011 · Cited by 5,581
Chronic kidney disease: global dimension and perspectives
Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., Saran, R., Wang, A. Y.-M., & Yang, C.-W. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60687-x · Cited by 4,383
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Royston, P., & Parmar, M. K. B. (2002) · Statistics in Medicine · doi:10.1002/sim.1203 · Cited by 1,529
Evolving importance of kidney disease: from subspecialty to global health burden
Eckardt, K.-U., Coresh, J., Devuyst, O., Johnson, R. J., Köttgen, A., Levey, A. S., & Levin, A. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60439-0 · Cited by 1,159
Identification and characterization of metabolically benign obesity in humans
Stefan, N. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1609 · Cited by 1,049
Kramer, C. K., Zinman, B., & Retnakaran, R. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-11-201312030-00008 · Cited by 961
Adjusted survival curves with inverse probability weights
Cole, S. R., & Hernán, M. A. (2004) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2003.10.004 · Cited by 814
Characterizing the profile of obese patients who are metabolically healthy
Primeau, V, Coderre, L., Karelis, A. D., Brochu, M., Lavoie, M.-E., Messier, V, Sladek, R., & Rabasa-Lhoret, R. (2011) · International Journal of Obesity · doi:10.1038/ijo.2010.216 · Cited by 637
Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease
de Vries, A. P. J., Ruggenenti, P., Ruan, X. Z., Praga, M., Cruzado, J. M., Bajema, I. M., D'Agati, V. D., Lamb, H. J., Barlovic, D. P., Hojs, R., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70065-8 · Cited by 500
Overweight, Obesity, and the Development of Stage 3 CKD: The Framingham Heart Study
Foster, M. C., Hwang, S.-J., Larson, M. G., Lichtman, J. H., Parikh, N. I., Vasan, R. S., Levy, D., & Fox, C. S. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.03.003 · Cited by 403
The number of years lived with obesity and the risk of all-cause and cause-specific mortality
Abdullah, A., Wolfe, R., Stoelwinder, J. U., de Courten, M., Stevenson, C., Walls, H. L., & Peeters, A. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr018 · Cited by 371
Malavolti, M., Mussi, C., Poli, M., Fantuzzi, A. L., Salvioli, G., Battistini, N., & Bedogni, G. (2003) · Annals of Human Biology · doi:10.1080/0301446031000095211 · Cited by 345
Mathiesen, U. L., Franzen, L. E., Åselius, H., Resjö, M., Jacobsson, L., Foberg, U., Frydén, A., & Bodemar, G. (2002) · Digestive and Liver Disease · doi:10.1016/s1590-8658(02)80111-6 · Cited by 340
Are Metabolically Normal but Obese Individuals at Lower Risk for All-Cause Mortality?
Kuk, J. L., & Ardern, C. I. (2009) · Diabetes Care · doi:10.2337/dc09-0574 · Cited by 286
Prediction equations to estimate glomerular filtration rate: an update
Manjunath, G., Sarnak, M. J., & Levey, A. S. (2001) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-200111000-00009 · Cited by 277
Metabolically-Healthy Obesity and Coronary Artery Calcification
Chang, Y., Kim, B.-K., Yun, K. E., Cho, J., Zhang, Y., Rampal, S., Zhao, D., Jung, H.-S., Choi, Y., Ahn, J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.042 · Cited by 272
Self-citationObesity and target organ damage: the kidney
for the PREVEND study group, de Jong, P., Verhave, J., Pinto-Sietsma, S., & Hillege, H. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802213 · Cited by 224
Obesity and Kidney Disease: Potential Mechanisms
Wickman, C., & Kramer, H. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.12.006 · Cited by 213
Thethi, T., Kamiyama, M., & Kobori, H. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0245-z · Cited by 178
The duration of obesity and the risk of type 2 diabetes
Abdullah, A., Stoelwinder, J., Shortreed, S., Wolfe, R., Stevenson, C., Walls, H., de Courten, M., & Peeters, A. (2011) · Public Health Nutrition · doi:10.1017/s1368980010001813 · Cited by 176
Chang, Y., Jung, H.-S., Yun, K. E., Cho, J., Cho, Y. K., & Ryu, S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.349 · Cited by 163
Self-citationMetabolically Healthy Obesity and Risk of Incident CKD
Hashimoto, Y., Tanaka, M., Okada, H., Senmaru, T., Hamaguchi, M., Asano, M., Yamazaki, M., Oda, Y., Hasegawa, G., Toda, H., et al. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08980914 · Cited by 156
Scope and mechanisms of obesity-related renal disease
Hunley, T. E., Ma, L., & Kon, V. (2010) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283374c09 · Cited by 147
Obesity rising to alarming levels around the world
McLellan, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08397-6 · Cited by 138
Zhang, Y., Chang, Y., Ryu, S., Cho, J., Lee, W., Rhee, E., Kwon, M., Pastor‐Barriuso, R., Rampal, S., Han, W. K., et al. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyu126 · Cited by 117
Self-citationThe role of obesity in kidney disease: recent findings and potential mechanisms
Kalaitzidis, R., & Siamopoulos, K. C. (2011) · International Urology and Nephrology · doi:10.1007/s11255-011-9974-1 · Cited by 63
Elevated body mass index as a risk factor for chronic kidney disease: current perspectives
Garland, J. S. (2014) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s46674 · Cited by 62
Stefan, N., Artunç, F., Heyne, N., Machann, J., Schleicher, E. D., & Häring, H. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu081 · Cited by 55
Cited by
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
Kovesdy, C. P., Furth, S. L., Zoccali, C., & on behalf of the World Kidney Day Steering Committee (2017) · American Journal of Nephrology · doi:10.1159/000458467 · Cited by 2,217
Epidemiology of Obesity and Diabetes and Their Cardiovascular Complications
Bhupathiraju, S. N., & Hu, F. B. (2016) · Circulation Research · doi:10.1161/circresaha.115.306825 · Cited by 945
Garofalo, C., Borrelli, S., Minutolo, R., Chiodini, P., De Nicola, L., & Conte, G. (2017) · Kidney International · doi:10.1016/j.kint.2016.12.013 · Cited by 363
Obesity phenotypes and their paradoxical association with cardiovascular diseases
Vecchié, A., Dallegri, F., Carbone, F., Bonaventura, A., Liberale, L., Portincasa, P., Frühbeck, G., & Montecucco, F. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.10.020 · Cited by 329
Obesity and chronic kidney disease
Jiang, Z., Wang, Y., Zhao, X., Cui, H., Han, M., Ren, X., Gang, X., & Wang, G. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00179.2022 · Cited by 267
Metadata
- Authors
- Chang, Y., Ryu, S., Choi, Y., Zhang, Y., Cho, J., Kwon, M.-J., Hyun, Y. Y., Lee, K.-B., Kim, H., Jung, H.-S., Yun, K. E., Ahn, J., Rampal, S., Zhao, D., Suh, B.-S., Chung, E. C., Shin, H., Pastor-Barriuso, R., & Guallar, E.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2016-03-01
- Volume
- 164
- Issue
- 5
- Pages
- 305-312
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2290487107
- Cited by
- 283
- References
- 32
- FWCI
- 32.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.